MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Predictors of Response to Botulinum Toxin Treatment in Patients With Hemifacial Spasm:A Prospective Study

    S. Jain, S. Pandey, RK. Garg, HS. Malhotra, I. Rizvi (Lucknow, India)

    Objective: To study the predictors of Good and Bad outcome and the impact on quality of life of patients with HFS following Botulinum toxin treatment.…
  • 2024 International Congress

    Can We Rid Uganda of the Societal Myth That Parkinson’s Disease Is Witchcraft?

    S. Klingelhofer, H. Tamale, G. Mogan (Tillamook, USA)

    Objective: Educate rural Ugandans that Parkinson’s Disease (PD) is a scientific disorder, not contagious or the result of anything mystical Background: People with PD (PWP)…
  • 2024 International Congress

    Movement disorders in Brain Sagging Syndrome- A Systematic Review

    A. Datta, A. Lenka (Minneapolis, USA)

    Objective: Objective: This study aims to systematically review the array of movement disorders observed in patients diagnosed with brain sagging syndrome (BSS) secondary to spontaneous…
  • 2024 International Congress

    PD Young Ambassadors: A Peer-led, Community-Based Intervention to Raise PD Awareness in the Hispanic Communities of Chicago.

    J. Deliz, E. Espinoza, S. Kola, E. Zivin, K. Williams, J. Adrissi, P. Gonzalez-Latapi, D. Larson (Chicago, USA)

    Objective: To employ a community-based participatory research (CBPR) approach in developing and testing a workshop-based, peer-led intervention aimed at increasing PD awareness among youth and…
  • 2024 International Congress

    Idiopathic Parkinson’s disease and Normal pressure Hydrocephalus – a tale of two sisters

    P. Vvsrk, S. Kola, R. Alugolu, R. Kandadani, R. Borgohain (Hyderabad, India)

    Objective: Idiopathic Parkinson's disease (PD) and Normal pressure hydrocephalus (NPH) can have similar clinical presentation. However, diagnostic precision is important as clinical management differs. Previous…
  • 2024 International Congress

    Real-Time Removal of Stimulus Artifact for Closed-Loop Deep Brain Stimulation by Synchronized Sample-And-Hold Artifact Blanking (SSAB): Verification in Animal Model

    YH. Wu, HC. Lin, CW. Huang, CC. Hsieh, MD. Ker (Hsinchu City, Taiwan)

    Objective: To develop and validate a real-time stimulus artifact removal analog front-end (AFE) by synchronized sample-and-hold artifact blanking (SSAB) technique with the Parkinsonian minipig model…
  • 2024 International Congress

    Clinical and Radiologic Predictors for a Longer Benefit of Cerebrospinal Fluid Decompression in Normal Pressure Hydrocephalus

    J. Lee, M. Sunwoo (Seongnam-si, Republic of Korea)

    Objective: To explore the clinical characteristics and predictors for longer benefit of gait after cerebrospinal fluid (CSF) decompression test in patients with normal pressure hydrocephalus…
  • 2024 International Congress

    Neural oscillatory dynamics in Parkinson disease and dystonia: Insights from EEG analysis

    M. Alam, A. Beck, K. Schwabe, J. Krauss (Hannover, Germany)

    Objective: Changes in total power and entropy across raw data may enable the identification of comprehensive shifts in neural dynamics that may align with clinical…
  • 2024 International Congress

    Utilizing a global network to study environmental factors relating to Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2)

    K. Atterling Brolin, L. Jones, B. Fiske, S. Jasaityte, H. Morris, A. Noyce (Lund, Sweden)

    Objective: To identify and collect data on non-genetic variables from individuals with and without Parkinson’s disease (PD) in the Global Parkinson’s Genetics Program (GP2, http://gp2.org/).…
  • 2024 International Congress

    Genetic Study of polymorphism of cytokines in Parkinson’s disease.

    S. Frikha, O. Ben Othmen, S. Fezai, A. Achouri, M. Ben Mahmoud, S. Fray, H. Jamoussi, M. Fredj, N. Ben Ali (Tunis, Tunisia)

    Objective: The aim of our study was to conduct a cohort that demonstrates genetic variations in cytokines genes involved in the physiopathology, the development and…
  • « Previous Page
  • 1
  • …
  • 297
  • 298
  • 299
  • 300
  • 301
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley